Board of Directors
Chris Xu, PhD / Chairman of the Board
Dr. Xu has served on the Board of Directors since March 2016. In November 2016, the board of directors elected Dr. Xu as president and chief executive officer. He brings over 15 years of leadership experience in the biopharmaceutical industry and has contributed to numerous successful product launches. In 2009, Dr. Xu founded Boyalife Group, a global diversified life sciences holding company and is currently the principal shareholder of ThermoGenesis Holdings, Inc. Prior to founding Boyalife, Dr. Xu served as a project leader at Pfizer, as a director of research at two publicly traded companies and as a vice president at Founder Group. Dr. Xu’s expertise spans several diverse therapeutic areas, including arthritis & inflammation, cardiovascular disease, autoimmunity, oncology, and diabetes. He has authored over forty publications and has been recognized by numerous professional societies for his contributions to biomedical research. Dr. Xu received his Ph.D. in immunology from Washington University School of Medicine (St. Louis, USA) and an executive MBA from Emory University (Atlanta, USA).
Biao Xi, PhD / Director
Dr. Biao Xi previously served as Chief Executive Officer at ImmunePoint Inc. and Vice President of Translational Study at Theragene Pharmaceuticals. He was also Chief Scientist for China at ACEA Biosciences from 2006 to 2018. Dr. Xi earned a master's degree from the Chinese Academy of Sciences and a Ph.D. from Zhejiang University in China.
Contact the Board
Stockholders and other interested parties who wish to communicate directly with any of the ThermoGenesis Holdings‘ Directors should submit such communications in writing to:
Board of Directors
ThermoGenesis Holdings, Inc.
2890 Kilgore Rd
Rancho Cordova, CA 95670